World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
99
Citations
59506
World Ranking
8413
National Ranking
4349

Overview

Steven H. Ferris was affiliated with New York University in the United States. Their research spanned several fields with a significant focus on Biochemistry, Genetics and Molecular Biology, Medicine, and Neuroscience. They contributed to subfields including Molecular Biology, Physiology, Neurology, Psychiatry and Mental Health, and Genetics.

Their work primarily centered on topics such as Alzheimer's disease research and treatments, dementia and cognitive impairment research, genetic associations and epidemiology, bioinformatics and genomic networks, diet and metabolism studies, microRNA in disease regulation, and neuroinflammation and neurodegeneration mechanisms.

Among their recent papers are the following:

  • Exceptionally low likelihood of Alzheimer's dementia in APOE2 homozygotes from a 5,000-person neuropathological study, 2020, Nature Communications
  • Novel Alzheimer Disease Risk Loci and Pathways in African American Individuals Using the African Genome Resources Panel, 2020, JAMA Neurology
  • The cognitive syndrome of vascular dementia: implications for clinical trials, 2022, PubMed
  • Manifestations of Alzheimer's disease genetic risk in the blood are evident in a multiomic analysis in healthy adults aged 18 to 90, 2022, Scientific Reports
  • Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifies LRRC4C, LHX5-AS1 and nominates ancestry-specific loci PTPRK, GRB14, and KIAA0825 as novel risk loci for Alzheimer's disease: the Alzheimer's Disease Genetics Consortium, 2023, bioRxiv (Cold Spring Harbor Laboratory)

Steven H. Ferris collaborated frequently with several co-authors, including:

  • Paul K. Crane
  • Joseph D. Buxbaum
  • Erin L. Abner
  • Lisa L. Barnes
  • Sandra Barral

Their publications appeared in various venues, with multiple articles in Nature Communications, JAMA Neurology, Scientific Reports, PubMed, and bioRxiv (Cold Spring Harbor Laboratory).

Best Publications

  • The Global Deterioration Scale for assessment of primary degenerative dementia.

    Reisberg B;Ferris Sh;de Leon Mj;Crook T

  • Memantine in Moderate-to-Severe Alzheimer's Disease

    Barry Reisberg;Rachelle Doody;Albrecht Stöffler;Frederick Schmitt

  • Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment

    Ronald C. Petersen;Ronald G. Thomas;Michael Grundman;David Bennett

  • Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.

    Adam C. Naj;Gyungah Jun;Gary W. Beecham;Li-San Wang

  • Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease

    Stephen Salloway;Reisa Sperling;Nick C. Fox;Kaj Blennow

  • Behavioral symptoms in Alzheimer's disease: Phenomenology and treatment.

    B Reisberg;J Borenstein;S P Salob;S H Ferris

  • Length of clinical trials of dementia drugs : Position paper from the international working group on harmonization of dementia drug guidelines

    Douglas Galasko;David Bennett;Mary Sano;Chris Ernesto

  • Diagnosis and treatment of Alzheimer disease and related disorders. Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society.

    Gary W. Small;Peter V. Rabins;Patricia P. Barry;Neil S. Buckholtz

  • Age‐associated memory impairment: Proposed diagnostic criteria and measures of clinical change — report of a national institute of mental health work group

    Thomas Crook;Raymond T. Bartus;Steven H. Ferris;Peter J. Whitehouse

  • A Family Intervention to Delay Nursing Home Placement of Patients With Alzheimer Disease: A Randomized Controlled Trial

    Mary S. Mittelman;Steven H. Ferris;Emma Shulman;Gertrude Steinberg

  • Mild cognitive impairment in the elderly: predictors of dementia.

    Charles Flicker;Steven H. Ferris;Barry Reisberg

  • Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials.

    Michael Grundman;Ronald C. Petersen;Steven H. Ferris;Ronald G. Thomas

  • Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease

    Rebecca Sims;Sven J. Van Der Lee;Adam C. Naj;Céline Bellenguez;Céline Bellenguez

  • The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers.

    John C. Morris;Sandra Weintraub;Helena C. Chui;Jeffrey Cummings

  • The Alzheimer's Disease Centers' Uniform Data Set (UDS): the neuropsychologic test battery.

    Sandra Weintraub;David Salmon;Nathaniel Mercaldo;Steven Ferris

  • An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

    Galasko D;Bennett D;Sano M;Ernesto C

  • The National Alzheimer's Coordinating Center (NACC) database: the Uniform Data Set.

    Duane L. Beekly;Erin M. Ramos;William W. Lee;Woodrow D. Deitrich

  • Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study.

    L S Schneider;J T Olin;R S Doody;C M Clark

  • Development of cognitive instruments for use in clinical trials of antidementia drugs: Additions to the Alzheimer's Disease Assessment Scale that broaden its scope.

    Richard C. Mohs;David Knopman;Ronald C. Petersen;Steven H. Ferris

  • Validity and reliability of the Alzheimer's Disease Cooperative Study–Clinical Global Impression of Change.

    Lon S. Schneider;Jason T. Olin;Rachelle S. Doody;Christopher M. Clark

Frequent Co-Authors

Barry Reisberg
Barry Reisberg New York University
Mary Sano
Mary Sano Icahn School of Medicine at Mount Sinai
Thomas H. Crook
Thomas H. Crook National Institutes of Health
Mony J. de Leon
Mony J. de Leon Cornell University
Lon S. Schneider
Lon S. Schneider University of Southern California
Paul S. Aisen
Paul S. Aisen University of Southern California
Rachelle S. Doody
Rachelle S. Doody Roche (Switzerland)
Douglas Galasko
Douglas Galasko University of California, San Diego
Jeffrey Kaye
Jeffrey Kaye Oregon Health & Science University
John C. Morris
John C. Morris Washington University in St. Louis

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re passionate about a healthcare career but not ready to commit to the traditional path of studying Medicine in the USA, there are flexible online options to consider. For example, those seeking advanced nursing roles may explore a dnp program without clinical hours, which is ideal for professionals aiming for leadership roles without the need for in-person clinical experience.

Interested in a quicker start to your nursing career? Consider an accelerated lpn pathway, allowing you to earn qualifications faster and start working as a nurse sooner. Mental health nursing is also in high demand, and flexible online msn pmhnp programs can help you specialize and advance in psychiatric care.

Not all healthcare roles require direct patient care. If you’re interested in the business, management, or administrative side of healthcare, check out the cheapest online healthcare administration degree options. These programs can prepare you for leadership roles without the high cost of traditional, on-campus degrees.

Best Scientists Citing Steven H. Ferris

Recently Published Articles